Cargando…

Aggressive Perioperative Management for Immune Thrombocytopenic Purpura in a Patient Undergoing Open Heart Surgery: A Correct Strategy in an Emergent Patient?

Immune thrombocytopenic purpura (ITP) is an autoimmune pathology that causes thrombocytopenia. This can become extremely troublesome when dealing with the rare clinical scenario of having to operate a highly invasive procedure on patients with thrombocytopenia. We report a case of a 66-year-old male...

Descripción completa

Detalles Bibliográficos
Autores principales: Mallick, Hamdan, Siddiqui, Sobia T, Khan, Yasir, Ahmad, Ismael, Shahabuddin, Syed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8553294/
https://www.ncbi.nlm.nih.gov/pubmed/34725582
http://dx.doi.org/10.7759/cureus.18310
_version_ 1784591548599500800
author Mallick, Hamdan
Siddiqui, Sobia T
Khan, Yasir
Ahmad, Ismael
Shahabuddin, Syed
author_facet Mallick, Hamdan
Siddiqui, Sobia T
Khan, Yasir
Ahmad, Ismael
Shahabuddin, Syed
author_sort Mallick, Hamdan
collection PubMed
description Immune thrombocytopenic purpura (ITP) is an autoimmune pathology that causes thrombocytopenia. This can become extremely troublesome when dealing with the rare clinical scenario of having to operate a highly invasive procedure on patients with thrombocytopenia. We report a case of a 66-year-old male with multiple comorbidities, including ITP, who underwent coronary artery bypass grafting (CABG) with an aortic valve replacement (AVR). He deteriorated rapidly, prompting urgent procedures. Little to no literature exists on the treatment plan for a critical patient with ITP who is about to undergo an open heart surgery. Our goal was to aggressively treat the patient with prednisolone, azathioprine, and platelets in the short preoperative time in order to maximize the prognosis. Our patient remained stable postoperatively, developed no complications, and was discharged successfully.
format Online
Article
Text
id pubmed-8553294
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-85532942021-10-31 Aggressive Perioperative Management for Immune Thrombocytopenic Purpura in a Patient Undergoing Open Heart Surgery: A Correct Strategy in an Emergent Patient? Mallick, Hamdan Siddiqui, Sobia T Khan, Yasir Ahmad, Ismael Shahabuddin, Syed Cureus Cardiac/Thoracic/Vascular Surgery Immune thrombocytopenic purpura (ITP) is an autoimmune pathology that causes thrombocytopenia. This can become extremely troublesome when dealing with the rare clinical scenario of having to operate a highly invasive procedure on patients with thrombocytopenia. We report a case of a 66-year-old male with multiple comorbidities, including ITP, who underwent coronary artery bypass grafting (CABG) with an aortic valve replacement (AVR). He deteriorated rapidly, prompting urgent procedures. Little to no literature exists on the treatment plan for a critical patient with ITP who is about to undergo an open heart surgery. Our goal was to aggressively treat the patient with prednisolone, azathioprine, and platelets in the short preoperative time in order to maximize the prognosis. Our patient remained stable postoperatively, developed no complications, and was discharged successfully. Cureus 2021-09-27 /pmc/articles/PMC8553294/ /pubmed/34725582 http://dx.doi.org/10.7759/cureus.18310 Text en Copyright © 2021, Mallick et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Cardiac/Thoracic/Vascular Surgery
Mallick, Hamdan
Siddiqui, Sobia T
Khan, Yasir
Ahmad, Ismael
Shahabuddin, Syed
Aggressive Perioperative Management for Immune Thrombocytopenic Purpura in a Patient Undergoing Open Heart Surgery: A Correct Strategy in an Emergent Patient?
title Aggressive Perioperative Management for Immune Thrombocytopenic Purpura in a Patient Undergoing Open Heart Surgery: A Correct Strategy in an Emergent Patient?
title_full Aggressive Perioperative Management for Immune Thrombocytopenic Purpura in a Patient Undergoing Open Heart Surgery: A Correct Strategy in an Emergent Patient?
title_fullStr Aggressive Perioperative Management for Immune Thrombocytopenic Purpura in a Patient Undergoing Open Heart Surgery: A Correct Strategy in an Emergent Patient?
title_full_unstemmed Aggressive Perioperative Management for Immune Thrombocytopenic Purpura in a Patient Undergoing Open Heart Surgery: A Correct Strategy in an Emergent Patient?
title_short Aggressive Perioperative Management for Immune Thrombocytopenic Purpura in a Patient Undergoing Open Heart Surgery: A Correct Strategy in an Emergent Patient?
title_sort aggressive perioperative management for immune thrombocytopenic purpura in a patient undergoing open heart surgery: a correct strategy in an emergent patient?
topic Cardiac/Thoracic/Vascular Surgery
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8553294/
https://www.ncbi.nlm.nih.gov/pubmed/34725582
http://dx.doi.org/10.7759/cureus.18310
work_keys_str_mv AT mallickhamdan aggressiveperioperativemanagementforimmunethrombocytopenicpurpurainapatientundergoingopenheartsurgeryacorrectstrategyinanemergentpatient
AT siddiquisobiat aggressiveperioperativemanagementforimmunethrombocytopenicpurpurainapatientundergoingopenheartsurgeryacorrectstrategyinanemergentpatient
AT khanyasir aggressiveperioperativemanagementforimmunethrombocytopenicpurpurainapatientundergoingopenheartsurgeryacorrectstrategyinanemergentpatient
AT ahmadismael aggressiveperioperativemanagementforimmunethrombocytopenicpurpurainapatientundergoingopenheartsurgeryacorrectstrategyinanemergentpatient
AT shahabuddinsyed aggressiveperioperativemanagementforimmunethrombocytopenicpurpurainapatientundergoingopenheartsurgeryacorrectstrategyinanemergentpatient